Free Trial

Antibe Therapeutics (ATBPF) Short Interest Ratio & Short Volume

Antibe Therapeutics logo
$0.22 0.00 (0.00%)
As of 04/16/2025

Antibe Therapeutics Short Interest Data

Antibe Therapeutics (ATBPF) has a short interest of 8,600 shares, representing 0.02% of the float (the number of shares available for trading by the public). This marks a 0.00% change in short interest from the previous month. The short interest ratio (days to cover) is 0.0, indicating that it would take 0.0 days of the average trading volume of 27,352 shares to cover all short positions.

Current Short Interest
8,600 shares
Previous Short Interest
8,600 shares
Change Vs. Previous Month
No Change
Dollar Volume Sold Short
$1,854.16
Short Interest Ratio
0.0 Days to Cover
Last Record Date
April 15, 2025
Outstanding Shares
52,981,000 shares
Short Percent of Float
0.02%
Today's Trading Volume
0 shares
Average Trading Volume
27,352 shares
Today's Volume Vs. Average
0%
Short Selling Antibe Therapeutics?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for Antibe Therapeutics and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

ATBPF Short Interest Over Time

ATBPF Days to Cover Over Time

ATBPF Percentage of Float Shorted Over Time

Antibe Therapeutics Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
4/15/20258,600 shares $1,854.16 No Change0.0%0 $0.22
3/31/20258,600 shares $1,854.16 No Change0.0%0 $0.22
3/15/20258,600 shares $1,854.16 No Change0.0%0 $0.22
2/28/20258,600 shares $1,854.16 No Change0.0%0 $0.22
2/15/20258,600 shares $1,854.16 No Change0.0%0 $0.22
1/31/20258,600 shares $1,854.16 -86.8%N/A0 $0.22
1/15/202565,100 shares $14,035.56 No ChangeN/A0 $0.22
12/31/202465,100 shares $14,035.56 No ChangeN/A0 $0.22
12/15/202465,100 shares $14,035.56 No ChangeN/A0 $0.22
11/30/202465,100 shares $14,061.60 No ChangeN/A0 $0.22
11/15/202465,100 shares $14,035.56 No ChangeN/A0 $0.22
10/31/202465,100 shares $14,035.56 No ChangeN/A0 $0.22
10/15/202465,100 shares $14,035.56 No ChangeN/A0 $0.22
9/30/202465,100 shares $14,035.56 No ChangeN/A0 $0.22
9/15/202465,100 shares $14,035.56 No ChangeN/A0 $0.22
8/31/202465,100 shares $14,035.56 No ChangeN/A0 $0.22
8/15/202465,100 shares $14,061.60 No ChangeN/A0 $0.22
7/31/202465,100 shares $14,061.60 No ChangeN/A0 $0.22
7/15/202465,100 shares $14,061.60 No ChangeN/A0 $0.22
6/30/202465,100 shares $14,035.56 No ChangeN/A0 $0.22
6/15/202465,100 shares $14,061.60 No ChangeN/A0 $0.22
5/31/202465,100 shares $14,061.60 No ChangeN/A0 $0.22
5/15/202465,100 shares $14,061.60 No ChangeN/A0 $0.22
4/30/202465,100 shares $14,035.56 No ChangeN/A0 $0.22
4/15/202465,100 shares $14,035.56 +1,934.4%N/A0.7 $0.22
3/31/20243,200 shares $1,070.40 -64.0%N/A0.1 $0.33
3/15/20248,900 shares $2,891.61 -73.1%N/A0.1 $0.32
2/29/202433,100 shares $23,653.26 +234.3%N/A0.5 $0.71
2/15/20249,900 shares $6,811.20 No ChangeN/A0.6 $0.69
1/15/202410,400 shares $8,112.00 -9.6%N/A1.4 $0.78
12/31/202311,500 shares $7,843.00 +121.2%N/A0.7 $0.68
12/15/20235,200 shares $3,571.88 -17.5%N/A1.1 $0.69
11/30/20236,300 shares $3,433.50 -54.0%N/A0.8 $0.55
11/15/202313,700 shares $7,521.30 +17.1%N/A0.1 $0.55
10/31/202311,700 shares $5,382.00 -27.8%N/A0.2 $0.46
10/15/202316,200 shares $5,799.60 +211.5%N/A1.7 $0.36
9/30/20235,200 shares $1,863.06 -24.6%N/A0.2 $0.36
9/15/20236,900 shares $2,829.00 -76.4%N/A0.3 $0.41
8/31/202329,200 shares $11,554.44 -22.8%N/A1.1 $0.40
8/15/202337,800 shares $15,498.00 +563.2%N/A1.5 $0.41
Trump’s Secret Social Security Plan? (Ad)

In less than a decade, Social Security could be out of money. But a surprising plan from Trump’s inner circle may not just save the system — it could unlock a major opportunity for savvy investors. Financial insider Jim Rickards calls it “Social Prosperity,” and says those who act now could see the biggest gains.

Find out how Trump’s plan could rescue your retirement
7/31/20235,700 shares $2,053.14 -8.1%N/A0.4 $0.36
7/15/20236,200 shares $2,156.98 No ChangeN/A2.8 $0.35
6/30/20236,200 shares $2,170.00 -7.5%N/A2.6 $0.35
6/15/20236,700 shares $2,517.19 -71.7%N/A1.6 $0.38
5/31/202323,700 shares $8,752.41 +203.9%N/A1.3 $0.37
5/15/20237,800 shares $2,934.36 -27.8%N/A0.6 $0.38
4/30/202310,800 shares $4,342.68 -6.9%N/A3.1 $0.40
4/15/202311,600 shares $4,637.68 -78.6%N/A3.6 $0.40
3/31/202354,100 shares $23,766.13 -1.3%N/A2.5 $0.44
3/15/202354,800 shares $20,643.16 +260.5%N/A1.2 $0.38
2/28/202315,200 shares $5,668.08 -37.5%N/A1.7 $0.37
2/15/202324,300 shares $10,529.19 +22.7%N/A4.9 $0.43
1/31/202319,800 shares $8,401.14 +94.1%N/A0.8 $0.42
1/15/202310,200 shares $5,115.81 -56.8%N/A4.3 $0.50
12/30/202223,600 shares $7,622.80 -23.1%N/A2.5 $0.32
12/15/202230,700 shares $11,666.00 +44.8%N/A2.8 $0.38
11/30/202221,200 shares $7,420.00 +32.5%N/A3.2 $0.35
11/15/202216,000 shares $5,912.00 +3.9%N/A1.3 $0.37
10/31/202215,400 shares $5,998.30 +12.4%N/A3.1 $0.39
10/15/202213,700 shares $5,555.35 -8.7%N/A3 $0.41
9/30/202215,000 shares $6,718.50 -41.4%N/A1.1 $0.45
9/15/202225,600 shares $12,170.24 -13.8%N/A2.8 $0.48
8/31/202229,700 shares $14,362.92 -15.1%N/A2.3 $0.48
8/15/202235,000 shares $17,570.00 -39.2%N/A3.3 $0.50
7/31/202257,600 shares $25,920.00 -26.9%N/A20.6 $0.45
7/15/202278,800 shares $37,248.76 +3.8%N/A17.1 $0.47
6/30/202275,900 shares $35,832.39 -5.8%N/A5.2 $0.47
6/15/202280,600 shares $38,833.08 +2.8%N/A6.3 $0.48
5/31/202278,400 shares $42,696.64 +5.0%N/A6.2 $0.54
5/15/202274,700 shares $39,591.00 +48.8%N/A6.2 $0.53
4/30/202250,200 shares $28,011.60 +8.9%N/A7 $0.56
4/15/202246,100 shares $27,293.51 +45.9%N/A3.7 $0.59
3/31/202231,600 shares $20,066.00 +3.3%N/A2.4 $0.64
3/15/202230,600 shares $17,448.12 -23.7%N/A1.6 $0.57
2/28/202240,100 shares $23,454.49 +74.4%N/A1.1 $0.58
2/15/202223,000 shares $12,811.00 +57.5%N/A1.5 $0.56
1/31/202214,600 shares $7,678.14 +630.0%N/A0.2 $0.53
1/15/20222,000 shares $1,115.80 -66.1%N/A0.1 $0.56
12/31/20215,900 shares $3,043.81 -65.7%N/A0.1 $0.52
12/15/202117,200 shares $8,536.36 -71.4%N/A0.4 $0.50
11/30/202160,100 shares $32,737.67 -41.1%N/A1.6 $0.54
11/15/2021102,000 shares $72,644.40 -42.3%N/A0.7 $0.71
10/29/2021176,800 shares $114,725.52 +665.4%N/A1.2 $0.65
10/15/202123,100 shares $18,225.90 +725.0%N/A0.4 $0.79
9/30/20212,800 shares $2,640.40 +180.0%N/A0 $0.94
9/15/20211,000 shares $948.40 +11.1%N/A0 $0.95
8/31/2021900 shares $900.00 -96.4%N/A0 $1.00
8/13/202124,700 shares $25,935.00 -88.2%N/A0.1 $1.05
7/30/2021208,400 shares $561,638.00 +10.7%N/A6.6 $2.70
7/15/2021188,200 shares $513,409.60 -0.1%N/A9.6 $2.73
Trump’s Secret Social Security Plan? (Ad)

In less than a decade, Social Security could be out of money. But a surprising plan from Trump’s inner circle may not just save the system — it could unlock a major opportunity for savvy investors. Financial insider Jim Rickards calls it “Social Prosperity,” and says those who act now could see the biggest gains.

Find out how Trump’s plan could rescue your retirement
6/30/2021188,300 shares $559,251.00 -3.7%N/A5.8 $2.97
6/15/2021195,500 shares $602,218.20 -8.2%N/A5.5 $3.08
5/28/2021212,900 shares $724,924.50 +8.0%N/A11 $3.41
5/14/2021197,200 shares $646,816.00 -5.6%N/A8.2 $3.28
4/30/2021208,900 shares $714,458.89 +6.8%N/A5.8 $3.42
4/15/2021195,600 shares $708,072.00 -12.6%N/A9.5 $3.62
3/31/2021223,700 shares $883,615.00 +41.5%N/A1.8 $3.95
3/15/2021158,100 shares $623,388.30 -54.4%N/A3.2 $3.94
2/26/2021346,600 shares $1.50 million +439.9%N/A2 $4.34
2/12/202164,200 shares $301,098.00 -17.3%N/A0.5 $4.69
1/29/202177,600 shares $219,297.60 +21.1%N/A1.8 $2.83
12/31/202028,600 shares $89,518.00 No ChangeN/A0.5 $3.13
11/30/202030,700 shares $9,513.93 +332.4%N/A0.1 $0.31
11/15/20207,100 shares $2,188.93 -64.5%N/A0.1 $0.31
10/30/202020,000 shares $4,800.00 No ChangeN/A0.2 $0.24
10/15/202020,000 shares $5,342.00 +52.7%N/A0.2 $0.27
9/30/202013,100 shares $3,445.30 No ChangeN/A0 $0.26
8/31/20201,300 shares $388.96 -93.1%N/A0 $0.30
8/14/202018,900 shares $5,934.60 -44.9%N/A0 $0.31
7/31/202034,300 shares $9,569.70 +2,350.0%N/A0.1 $0.28
7/15/20201,400 shares $408.52 -92.4%N/A0 $0.29
6/30/202018,300 shares $5,574.18 -36.2%N/A0 $0.30
6/15/202028,700 shares $10,705.10 +135.3%N/A0 $0.37
5/29/202012,200 shares $3,782.00 +281.3%N/A0.1 $0.31
5/15/20203,200 shares $1,856.00 -98.3%N/A0 $0.58
4/30/2020191,600 shares $101,548.00 +787.0%N/A0.6 $0.53

ATBPF Short Interest - Frequently Asked Questions

What is Antibe Therapeutics' current short interest?

Short interest is the volume of Antibe Therapeutics shares that have been sold short but have not yet been closed out or covered. As of April 15th, investors have sold 8,600 shares of ATBPF short. 0.02% of Antibe Therapeutics' shares are currently sold short. Learn More on Antibe Therapeutics' current short interest.

What is a good short interest percentage for Antibe Therapeutics?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.02% of Antibe Therapeutics' floating shares are currently sold short.

How does Antibe Therapeutics' short interest compare to its competitors?

0.02% of Antibe Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Antibe Therapeutics: Skye Bioscience, Inc. (14.88%), HST Global, Inc. (0.00%), Verrica Pharmaceuticals Inc. (10.85%), Provectus Biopharmaceuticals, Inc. (0.00%), Rafael Holdings, Inc. (0.63%), Xilio Therapeutics, Inc. (3.55%), Spero Therapeutics, Inc. (1.54%), Shattuck Labs, Inc. (4.14%), Reviva Pharmaceuticals Holdings, Inc. (15.65%), Lantern Pharma Inc. (3.40%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($21.71 billion), iShares 20+ Year Treasury Bond ETF ($9.48 billion), Strategy Incorporated ($8.92 billion), Charter Communications, Inc. ($3.86 billion), Apollo Global Management, Inc. ($3.86 billion), Capital One Financial Co. ($3.72 billion), Super Micro Computer, Inc. ($3.47 billion), AppLovin Co. ($2.64 billion), VanEck Semiconductor ETF ($2.46 billion), and The Kroger Co. ($2.33 billion). View all of the most shorted stocks.

What does it mean to sell short Antibe Therapeutics stock?

Short selling ATBPF is an investing strategy that aims to generate trading profit from Antibe Therapeutics as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Antibe Therapeutics?

A short squeeze for Antibe Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of ATBPF, which in turn drives the price of the stock up even further.

How often is Antibe Therapeutics' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ATBPF, twice per month. The most recent reporting period available is April, 15 2025.




This page (OTCMKTS:ATBPF) was last updated on 4/26/2025 by MarketBeat.com Staff
From Our Partners